Transactions

Selected transactions which showcase the breadth of our experience to date.

1

2025 - present

$250m

Advisor to Various parties on structuring and capital raise for Corinthian

1

2025

Advisor to Members Agents on the buy-out of names on Lancashire Syndicate 2010
2

2025

Advisor
GP Financing

1

Nature Coast Re Ltd. (Series 2025-2)

Bermuda based SPV

2025

$150m

Indemnity

Acted as a Swiss & UK Placement Agent

2

2025

Consultant to Patriot Select on a capital raise

1

Nature Coast Re Ltd. (Series 2025-1)

Bermuda based SPV

2025

$200m

State-Weighted Index

Acted as Swiss & UK Placement Agent

1

Undisclosed

Syndicate 1966

2024-present

£98m

Undisclosed

Annual raise for Funds at Lloyd’s of London​

1

Syndicate 1985

2022 - present

c.£440m

Annual raise for Funds at Lloyd’s of London​

1

Syndicate 1699

2021 - present

Undisclosed

Annual raise for Funds at Lloyd’s of London

1

Undisclosed

Syndicate 1902

2021 - present

c.£250m

Undisclosed

Annual raise for Funds at Lloyd’s of London

2

Catawba Insurance

2024

Advisor to AssuranceAmerica on its acquisition of Catawba Insurance
2

2024

Advisor to MCIM on its sale

1

Nature Coast Re Ltd. (Series 2024-1)

Bermuda based SPV

2024

$50m

Indemnity

Acted as Swiss & UK Placement Agent

1

Undisclosed

2022-2024

Undisclosed

Annual raise for Funds at Lloyd’s of London​
2

2023

$15m

Surplus Notes for Capital increase/M&A

2

2023

Formation of Reciprocal Exchange

2

2023

Formation of Reciprocal Exchange

1

UK MGA

2023

$100m

Advisor to UK MGA in sale of a minority stake to an institutional trade investor

Trade Capital

1

2023

c.$100m

Advisor to Apiary Capital on the Acquisition of Carbon Underwriting​

1

2023

$75m

Advisor to Helios on a debt raise

1

2023

Undisclosed

Advised Investors and Management on the MBO of Nirvana from Castel

1

2022

$150m

Underwriting Capital

1ARCAS LTD ENGAGEMENT, 2ARCAS, LLC ENGAGEMENT
Cat Bonds
Company Text
SPV Text
$20000
Acted Text
Funds at Lloyd’s
Syndicate
24
$20000
Explainer
Investment Banking/Capital Raising Title
2025
Open text area. To use or not to use
Retrospective
2025
United States of America
$20000
Transfer/Close
Explainer

Transaction Overview

On December 31, 2025, Goodlife Solutions, Inc., the intermediate holding company of Blue Cross Blue Shield of Nebraska, Inc. (“BCBSNE”), completed a $100 million Senior Term Loan offering. BCBSNE is the leading health insurance provider in Nebraska, and the proceeds from the Senior Term Loan will be down streamed to BCBSNE in the form of a surplus note. This additional surplus will further strengthen BCBSNE’s already solid financial position as it advances its growth strategy across government programs.

BCBSNE is a member of the Blue Cross Blue Shield Association, which is comprised of over 30 plans and collectively provides healthcare coverage to nearly one third of all Americans. Founded in 1939, BCBSNE is the leading health insurer for group markets in Nebraska. The company generates approximately $2.6 billion in annual revenue and serves more than 600,000 members.

The Senior Term Loan was privately placed by a syndicate led by Synovus Bank.

Acrisure Re Corporate Advisory and Solutions (“ARCAS”) served as exclusive financial advisor to BCBSNE for this transaction.

Client Testimonial

“Acrisure’s responsiveness and reputation helped make this deal possible. Their preliminary work, connections, and due diligence guided us through our search for top quality partners that met our needs at favorable terms. Tom and his team walked with us through the entire process and helped us find the right deal and the right fit for our needs. I highly recommend Acrisure for anyone looking for a trusted advisor in this space.”

Acrisure Re Corporate Advisory & Solutions

ARCAS served as the exclusive financial advisor to Blue Cross Blue Shield of
Nebraska, providing:

  • Identification of syndicate participants
  • Advisory support on loan structuring and negotiations
*The experiences of the featured client are not indicative of the experience of all clients, and you should not expect similar results. Past performance may not be indicative of future results.